Publications by authors named "Jason Brunetta"

Claim this Profile
E
Efficacy and Safety of Long-Acting Subcutaneous Lenacapavir in Heavily Treatment-Experienced People with Multidrug-Resistant HIV-1: Week 104 Results of a Phase 2/3 Trial.
Onyema Ogbuagu, Jean-Michel Molina, Ploenchan Chetchotisakd, Moti N Ramgopal, William Sanchez, Jason Brunetta

Clin Infect Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real-world insights from BICSTaR cohorts.
Stefan Esser, Jason Brunetta, Alexy Inciarte, Itzchak Levy, Antonella D'Arminio Monforte

HIV Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV from the Canadian cohort of the observational BICSTaR study.
Alexander Wong, Jason Brunetta, Joss De Wet, Ken Logue, Hugues Loemba

Medicine (Baltimore)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Community and Health Care Provider Preferences for Bacterial Sexually Transmitted Infection Testing Interventions for Gay, Bisexual, and Other Men Who Have Sex With Men: e-Delphi Study.
Anna Yeung, Ryan Lisk, Jayoti Rana, Charlie B Guiang, Jean Bacon, Jason Brunetta

J Med Internet Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-sectional comparison of age- and gender-related comorbidities in people living with HIV in Canada.
Jason M Brunetta, Jean-Guy Baril, Joseph J de Wet, Chris Fraser, Gary Rubin

Medicine (Baltimore)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in renal and metabolic indices after switching from tenofovir disoproxil fumarate- to tenofovir alafenamide-containing ART among individuals with HIV in Canada: A retrospective study.
Mostafa Shokoohi, Meenakshi Gupta, Fred Crouzat, Graham Smith, Colin Kovacs, Jason Brunetta

Int J STD AIDS· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Onyema Ogbuagu, Peter J Ruane, Daniel Podzamczer, Laura C Salazar, Keith Henry, Jason M Brunetta

Lancet HIV· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survey of Health Care Providers' Practices and Opinions Regarding Bacterial Sexually Transmitted Infection Testing Among Gay, Bisexual, and Other Men Who Have Sex With Men.
Jayoti Rana, Charlie B Guiang, Ryan Lisk, Rita Shahin, Jason Brunetta

Sex Transm Dis· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HPV genotyping and risk factors for anal high-risk HPV infection in men who have sex with men from Toronto, Canada.
Yoojin Choi, Mona Loutfy, Robert S Remis, Juan Liu, Anuradha Rebbapragada, Jason Brunetta

Sci Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Events in an Inner-City HIV Clinic and Relationship to Abacavir Versus Tenofovir Disoproxil Fumarate-Containing Antiretroviral Regimens.
Brenda Varriano, Frederic Crouzat, Ina Sandler, Graham Smith, Colin Kovacs, Jason Brunetta

AIDS Res Hum Retroviruses· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period.
Sean B Rourke, Tsegaye Bekele, Anita Rachlis, Colin Kovacs, Jason Brunetta

AIDS· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Community-Directed Bacterial Sexually Transmitted Infection Testing Interventions Among Men Who Have Sex With Men: Protocol for an E-Delphi Study in Toronto, Canada.
Ann N Burchell, Ryan Lisk, Anna Yeung, Jayoti Rana, Jean Bacon, Jason Brunetta

JMIR Res Protoc· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of antiretroviral third agent virologic durability after initiation of first antiretroviral regimen.
Brenda Varriano, Ina Sandler, Mona Loutfy, Samantha Steinberg, Graham Smith, Jason Brunetta

Int J STD AIDS· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prosecution of non-disclosure of HIV status: Potential impact on HIV testing and transmission among HIV-negative men who have sex with men.
Maya A Kesler, Rupert Kaul, Mona Loutfy, Ted Myers, Jason Brunetta

PLoS One· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Sexually Transmitted Viral and Bacterial Infections in HIV-Positive and HIV-Negative Men Who Have Sex with Men in Toronto.
Robert S Remis, Juan Liu, Mona R Loutfy, Wangari Tharao, Anuradha Rebbapragada, Jason Brunetta

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B-Coinfected Adults.
Joel Gallant, Jason Brunetta, Gordon Crofoot, Paul Benson, Anthony Mills

J Acquir Immune Defic Syndr· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: A Randomized, Double-Blind Comparison of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate, Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine for Initial HIV-1 Treatment: Week 96 Results.
David Wohl, Shinichi Oka, Nathan Clumeck, Amanda Clarke, Cynthia Brinson, Jason Brunetta

J Acquir Immune Defic Syndr· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to Viremia for Patients Taking their First Antiretroviral Regimen and the Subsequent Resistance Profiles.
Frederic Crouzat, Anita C Benoit, Colin Kovacs, Graham Smith, Nathan Taback, Jason Brunetta

HIV Clin Trials· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to virologic failure for patients taking their first antiretroviral regimen and the subsequent resistance profiles.
Frederic Crouzat, Anita Benoit, Colin Kovacs, Graham Smith, Nathan Taback, Jason Brunetta

J Int AIDS Soc· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study.
Anthony Mills, Jose R Arribas, Jaime Andrade-Villanueva, Giovanni DiPerri, Jan Van Lunzen, Jason Brunetta

Lancet Infect Dis· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of raltegravir in the semen of HIV-infected men.
Tony Antoniou, Mona R Loutfy, Jason Brunetta, Graham Smith, Roberta Halpenny

Antivir Ther· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcomes After a Switch to a Single-Tablet Regimen of Rilpivirine, Emtricitabine, and Tenofovir DF in HIV-1-Positive, Virologically Suppressed Individuals: Additional Findings From a Randomized, Open-Label, 48-Week Trial.
Jason Brunetta, Santiago Moreno Guillén, Andrea Antinori, Patrick Yeni, Barbara Wade

Patient· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature.
Amy R Zipursky, David Gogolishvili, Sergio Rueda, Jason Brunetta, Adriana Carvalhal

AIDS· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Herpes simplex virus type 2 coinfection does not accelerate CD4 count decline in untreated HIV infection.
Darrell H S Tan, Janet M Raboud, Rupert Kaul, Jason Brunetta, Charu Kaushic

Clin Infect Dis· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of maraviroc, raltegravir, darunavir, and etravirine in the semen of HIV-infected men.
Tony Antoniou, Sumaira Hasan, Mona R Loutfy, Colin Kovacs, Jason Brunetta

J Acquir Immune Defic Syndr· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis